Mark Muzi

8PUBLICATIONS
188CO-AUTHORS
Predictive and prognostic markersMedical infection agents (incl. prions)Semi- and unsupervised learningMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Mar 27, 2024
Repeatability of 18F-FDG uptake in metastatic bone lesions of breast cancer patients and implications for accrual to clinical trials.

Mark Muzi, Lanell M Peterson, Jennifer M Specht

|Feb 05, 2024
Repeatability of 18F-FDG uptake in metastatic bone lesions of breast cancer patients and implications for accrual to clinical trials.

Mark Muzi, Lanell M Peterson, Jennifer M Specht

|Feb 24, 2023
Evaluation of Apparent Diffusion Coefficient Repeatability and Reproducibility for Preclinical MRIs Using Standardized Procedures and a Diffusion-Weighted Imaging Phantom.

Dariya Malyarenko, Ghoncheh Amouzandeh, Stephen Pickup

|Dec 05, 2022
Federated learning enables big data for rare cancer boundary detection.

Sarthak Pati, Ujjwal Baid, Brandon Edwards

|Apr 30, 2021
Whole-Body [18F]-Fluoride PET SUV Imaging to Monitor Response to Dasatinib Therapy in Castration-Resistant Prostate Cancer Bone Metastases: Secondary Results from ACRIN 6687.

Mark Muzi, Finbarr O'Sullivan, Timothy G Perk

|Jun 15, 2018
ACRIN 6684: Multicenter, phase II assessment of tumor hypoxia in newly diagnosed glioblastoma using magnetic resonance spectroscopy.

Eva-Maria Ratai, Zheng Zhang, James Fink

Pageof 2

Frequent Collaborators

2 joint publications

Patrick Foley

2 joint publications

Philipp Vollmuth

2 joint publications

Chiharu Sako

2 joint publications

Deepthi Karkada